Compound News and Research

RSS

Study shows potential treatment for brain cancer

A compound that kills cancer can sneak past the blood brain barrier, which protects the brain from foreign substances, to do its work in fighting a particularly invasive brain cancer, according to a new Saint Louis University animal study published in the Proceedings of the National Academy of Sciences Online Early Edition the week of Aug. 22.

22 Aug 2005

New FDA and USDA approved compound for Salmonella reduction in poultry processing

Solution BioSciences, Inc., has announced a new antimicrobial system, called Bromitize, to reduce salmonella and other carcass bacteria during poultry processing.

22 Aug 2005

Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections

According to the medical records of 26 children diagnosed with the disease, oral medications reduced levels of a compound in the blood called hemoglobin A1C by an average of 2 percentage points.

15 Aug 2005

Little convincing evidence that dietary antioxidant supplements such as vitamin E prevent heart disease

Instead there has been a surprise finding, which relates to a synthetic antioxidant, the drug Probucol, which is no longer prescribed in Australia.

11 Aug 2005

Curry spice may help fight oesophageal cancer

Welsh researchers apparently believe a spice used in curry may possibly prevent people from developing cancer of the gullet.

10 Aug 2005

Endorphin system may hold the key to understanding and treating bulimia nervosa

The role of the brain's opioid receptor system - or endorphin system - may hold the key to understanding and treating bulimia nervosa, according to research reported in the Society of Nuclear Medicine's August issue of the Journal of Nuclear Medicine.

9 Aug 2005

New theory as to why some people die during sleep

According to scientists the reason why some people stop breathing fatally in their sleep, is because a cumulative loss of cells in the area of the brain that controls breathing triggers a condition called central sleep apnoea.

9 Aug 2005

Nighttime dying linked to sleep apnea from brain cell loss

Aim to grow old and die peacefully in your sleep? Be careful what you wish for. A new UCLA study suggests that some people die in their sleep because they stop breathing due to a cumulative loss of cells in the brain's breathing command-post. The online edition of Nature Neuroscience reports the findings.

7 Aug 2005

Genelabs drug discovery team advances compounds against the hepatitis C virus

Genelabs Technologies today announced that a non-nucleoside compound from its internal Hepatitis C virus (HCV) drug discovery program has advanced into preclinical development.

4 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Research to investigate new drug for Parkinsons disease

Researchers at the University of Sydney have received a grant to investigate the potential of a new drug to treat the abnormal posture and balance that affects people with Parkinson's disease ultimately confining them to a wheelchair.

2 Aug 2005

Heparinase I is not a suitable replacement for protamine

The results of an international clinical trial led by Duke University Medical Center researchers has shown that a new drug is not a suitable replacement for protamine, a drug that has been used for more than 40 years after coronary artery bypass surgery to return thinned blood to its normal state.

1 Aug 2005

New insight into how protein E75 may control circadian rhythms and metabolic processes

University of Toronto researchers have gained new insight into how a specific protein may control circadian rhythms and metabolic processes, which has implications for treating cholesterol-related diseases.

28 Jul 2005

Pharmaceutical direct-to-consumer to evolve holistically

Restrictions against using brand names have rendered pharmaceutical Direct-to-Consumer Advertising (DTCA) in Europe an informative rather than promotional exercise. DTCA is now broadening its scope, evolving from its narrow publicity orientation to a more comprehensive approach focused on improved patient outcomes and value addition.

27 Jul 2005

New chemical compound can accelerate stem cell mobilization

The finding has led to the development of a new chemical compound that can accelerate this process (called stem cell mobilization) in mice - which could eventually lead to more efficient stem cell harvesting for human use.

26 Jul 2005

Arsenic caused the madness of King George III

According to a newly released study, high concentrations of arsenic have been found in a sample of King George III's hair, and this, say the authors, may have contributed to his unusually severe and prolonged bouts of madness.

23 Jul 2005

Arsenic in King George III's hair contributed to bouts of madness

A study revealing high concentrations of arsenic in a sample of King George III’s hair is published in this week’s issue of The Lancet. The authors believe the presence of arsenic in the King’s hair contributed to his unusually severe and prolonged bouts of madness.

21 Jul 2005

Intestinal hormone secretin should not be used to treat autism

The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.

19 Jul 2005

Studies explore genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2

Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.

19 Jul 2005

Compound derived from cottonseed could help improve the effectiveness of chemotherapy at treating head and neck cancer

The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.

18 Jul 2005